{"nct_id":"NCT05935085","title":"This Study Will Evaluate the Safety, Tolerability, and Efficacy of ANB032 in Subjects with Moderate to Severe Atopic Dermatitis (AD).","status":"TERMINATED","status_verified_date":"2024-08","start_date":"2023-06-13","start_date_type":"ACTUAL","primary_completion_date":"2024-10-16","primary_completion_date_type":"ACTUAL","completion_date":"2025-01-07","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["ANAB"]}